| NOVOCURE LTD |
| Großbritannien |
| Gesundheit |
| JE00BYSS4X48 / A140ML |
| 038 (Frankfurt) / NVCR (NASDAQ) |
| FRA:038, ETR:038, 038:GR, NASDAQ:NVCR |
| - |
| https://www.novocure.com/ |
|
Novocure Ltd. is a medical device company speciali..
>Volltext.. |
| 943.89 Mio. EUR |
| 740.76 Mio. EUR |
| 539.75 Mio. EUR |
| -136.33 Mio. EUR |
| -149.29 Mio. EUR |
| -1.35 EUR |
| 670.57 Mio. EUR |
| 289.63 Mio. EUR |
| -28.97 Mio. EUR |
| 1.34 |
| 5.48% |
| -12.54% |
| - |
| - |
| - |
| - |
| NOVOCURE |
| 12.02.26 |